Forefront Analytics LLC Buys 26 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)

Forefront Analytics LLC boosted its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 8.9% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 319 shares of the biopharmaceutical company’s stock after buying an additional 26 shares during the period. Forefront Analytics LLC’s […]

Related Keywords

Canada ,United States ,Hong Kong ,America ,Michaels Brown ,Sanfordc Bernstein ,Leonards Schleifer , ,Nasdaq ,Quarter For Regeneron Pharmaceuticals ,Securities Exchange Commission ,Royal Bank ,Regeneron Pharmaceuticals ,Regeneron Pharmaceuticals Price Performance ,Nebula Research Development ,Morgan Stanley ,Forefront Analytics ,Regeneron Pharmaceuticals Company Profile ,Hong Kong Ltd ,Regeneron Pharmaceuticals Inc ,News Ratings For Regeneron Pharmaceuticals Daily ,Caxton Associates ,Free Report ,Asset Managment ,Kong Ltd ,Partners Management ,Nebula Research ,Get Free Report ,Director Michael ,Exchange Commission ,Visit Holdingschannel ,Regeneron Pharmaceuticals Daily ,